CN112341506A - Acetyl glucose thiadiazole benzamide compound and synthesis method and application thereof - Google Patents

Acetyl glucose thiadiazole benzamide compound and synthesis method and application thereof Download PDF

Info

Publication number
CN112341506A
CN112341506A CN202011256567.7A CN202011256567A CN112341506A CN 112341506 A CN112341506 A CN 112341506A CN 202011256567 A CN202011256567 A CN 202011256567A CN 112341506 A CN112341506 A CN 112341506A
Authority
CN
China
Prior art keywords
thiadiazole
raw material
benzamide compound
acetylglucose
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202011256567.7A
Other languages
Chinese (zh)
Other versions
CN112341506B (en
Inventor
陈美航
罗海荣
张迅
鲁道旺
陈美云
马关康
王贤
李娜
董长军
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tongren University
Original Assignee
Tongren University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tongren University filed Critical Tongren University
Priority to CN202011256567.7A priority Critical patent/CN112341506B/en
Publication of CN112341506A publication Critical patent/CN112341506A/en
Application granted granted Critical
Publication of CN112341506B publication Critical patent/CN112341506B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/82Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with three ring hetero atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

The invention discloses an acetyl glucose thiadiazole benzamide compound and a synthesis method and application thereof, belonging to the technical field of chemical synthesis, wherein the structural general formula of the acetyl glucose thiadiazole benzamide compound is as follows:

Description

Acetyl glucose thiadiazole benzamide compound and synthesis method and application thereof
Technical Field
The invention relates to the technical field of chemical synthesis, in particular to an acetyl glucose thiadiazole benzamide compound and a synthesis method and application thereof.
Background
The potato late blight is a destructive disease caused by phytophthora infestans, has the characteristics of wide occurrence range, high epidemic speed and serious harm, can reduce the yield by 10-20% in general years, can reach 50-70% in serious harm years, and even cannot be harvested. At present, due to the degeneration of disease resistance of varieties and imperfect agricultural management, the prevention and treatment of the potato late blight mainly depends on chemical prevention and treatment. The medicaments for preventing and treating potato late blight mainly comprise protective medicaments such as copper hydroxide, mancozeb, fentin, iprodione, chlorothalonil, fluopicolide, cyazofamid and the like; propamocarb, metalaxyl, cymoxanil, dimethomorph and other therapeutic agents, and matrine, eugenol and other biological source bactericides. However, the use of these chemicals for controlling potato late blight brings about problems such as: the long-term use of the traditional chemical pesticide can lead pathogens to gradually generate resistance, and the use amount of the pesticide is continuously increased, thus leading the problem of more serious ecological environment; and most of the traditional chemical bactericides kill pathogenic bacteria and poison beneficial microorganisms and natural enemies of insects and pests.
Therefore, creating a novel, efficient and environmentally friendly bactericide is a real problem that needs to be solved urgently in the current agricultural production.
Disclosure of Invention
The embodiment of the invention aims to provide an acetyl glucose thiadiazole benzamide compound so as to solve the problems in the background technology.
In order to achieve the above purpose, the embodiments of the present invention provide the following technical solutions:
an acetyl glucose thiadiazole benzamide compound has a structural general formula as shown in formula I:
Figure BDA0002773301790000021
wherein R is a substituent at any position on the ring.
Preferably, in the formula, R is H or 2-CH3、3-CH3、4-CH3、2-OCH3、3-OCH3、4-OCH3、2,3-(CH3)2、2,4-(CH3)2、2,5-(CH3)2、2,6-(CH3)2、2,3-(OCH3)2、2,4-(OCH3)2、2,5-(OCH3)2、2,6-(OCH3)2、2-F、3-F、4-F、2-Cl、3-Cl、4-Cl、2-Br、3-Br、4-BrPh、2-NO2、3-NO2、4-NO2、2-CF3、3-CF3、4-CF3At least one of (1).
Another objective of the embodiments of the present invention is to provide a method for synthesizing the aforementioned acetylglucose thiadiazole benzamide compound, which comprises the following steps:
reacting the raw material A with the raw material B to obtain an intermediate C;
reacting the intermediate C with a raw material D to obtain the acetylglucose thiadiazole benzamide compound;
the structural formulas of the raw material A, the raw material B, the intermediate C and the raw material D are respectively shown as a formula A, a formula B, a formula C and a formula D:
Figure BDA0002773301790000022
preferably, the step of reacting the raw material a with the raw material B to obtain the intermediate C specifically includes:
mixing B, NaOH raw materials, distilled water and acetone to obtain a first mixed solution;
and preparing the raw material A into a solution, dropwise adding the solution into the first mixed solution for reaction, and then purifying and separating to obtain an intermediate C.
Preferably, in the step, the raw material A is prepared into an acetone solution of the raw material A.
Preferably, the step of reacting the intermediate C with the raw material D to obtain the acetylglucose thiadiazole benzamide compound specifically includes:
mixing the intermediate C, dichloromethane and triethylamine to obtain a second mixed solution;
and (3) mixing the raw material D with thionyl chloride, reacting completely, removing the thionyl chloride, preparing the residue into triethylamine solution, dropwise adding the triethylamine solution into the second mixed solution, reacting, and purifying and separating to obtain the acetylglucose thiadiazole benzamide compound.
Preferably, in this step, the residue is formulated as a solution of the acid chloride in methylene chloride.
Specifically, the reaction route of the synthesis method is as follows:
Figure BDA0002773301790000031
the embodiment of the invention also aims to provide application of the acetylglucose thiadiazole benzamide compound in inhibiting potato late blight pathogenic bacteria.
Compared with the prior art, the embodiment of the invention has the beneficial effects that:
the acetyl glucose thiadiazole benzamide compound provided by the embodiment of the invention is simple in synthesis method, is an efficient and environment-friendly bactericide, can be applied to agricultural sterilization, particularly has a good inhibition effect on the activity of potato late blight pathogenic bacteria, and can be used for preventing and reducing the occurrence of potato late blight.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments.
Example 1
The material embodiment provides a synthesis method of an acetyl glucose thiadiazole benzamide compound, and the reaction route is as follows, wherein R is a substituent on a ring where R is located, and is specifically 4-CH3
Figure BDA0002773301790000041
Specifically, the synthesis method comprises the following steps:
s1, synthesis of intermediate (2-amino-5- (thio-1, 3, 4-thiadiazolyl) -2 ', 3', 4 ', 6' -tetra-O-acetyl- β -D-glucose): adding 400mg (0.01mol) of NaOH, 10mL of distilled water, 50mL of acetone solution and 1.33g (0.01mol) of 2-amino-5-mercapto-1, 3, 4-thiadiazole into a 50mL three-necked bottle, and stirring for 30min to obtain a first mixed solution; 0.98g (2.4mmo1) of 2 ', 3', 4 ', 6' -tetra-O-acetyl-. alpha. -D-bromoglucose was dissolved in 5mL of acetone solution and added dropwise to the first mixed solution to conduct a reaction, stirred at room temperature, checked by TLC, developing solvent: v (ethyl acetate): v (petroleum ether) ═ 1: 2. When the reaction was complete, the solvent was removed by rotary evaporation under reduced pressure, 200mL of dichloromethane were added to the bottle containing the residue, washed 2 times with water (2X 20mL), the aqueous phase was extracted 2 times with dichloromethane (2X 20mL), and the organic phases were combined. Drying the organic phase by anhydrous magnesium sulfate, filtering, decompressing, spin-drying and removing the solvent to obtain a crude product, and separating by silica gel column chromatography to obtain an intermediate (2-amino-5- (sulfo-1, 3, 4-thiadiazolyl) -2 ', 3', 4 ', 6' -tetra-O-acetyl-beta-D-glucose).
S2, dissolving 2.54mmol (0.345g) of raw material D with the structural formula of the following formula D in 4 mL of thionyl chloride in a 50mL three-neck flask, carrying out reflux reaction at 60 ℃ for 2 hours, fully spin-drying a reaction system, adding 1.0mmol of the intermediate (2-amino-5- (thio-1, 3, 4-thiadiazolyl) -2 ', 3', 4 ', 6' -tetra-O-acetyl-beta-D-glucose), 10mL of dichloromethane and triethylamine (TEA, 1.0mmol), stirring at room temperature, slowly dropwise adding a dichloromethane solution of 1.2mmol of acyl chloride, stirring for three hours, carrying out TLC tracking reaction, after the reaction is completed, quenching with water, separating out an organic phase, spin-drying, and recrystallizing a crude product with isopropanol to obtain the acetylglucose thiadiazole benzamide compound. Wherein the structural formula of the raw material D is as follows:
Figure BDA0002773301790000051
example 2
The material embodiment provides a synthesis method of an acetyl glucose thiadiazole benzamide compound, which has the following reaction route, wherein R is a substituent on a ring where the R is located, and specifically is 4-F:
Figure BDA0002773301790000052
specifically, the synthesis method comprises the following steps:
s1, synthesis of intermediate (2-amino-5- (thio-1, 3, 4-thiadiazolyl) -2 ', 3', 4 ', 6' -tetra-O-acetyl- β -D-glucose): adding 400mg (0.01mol) of NaOH, 10mL of distilled water, 50mL of acetone solution and 1.33g (0.01mol) of 2-amino-5-mercapto-1, 3, 4-thiadiazole into a 50mL three-necked bottle, and stirring for 30min to obtain a first mixed solution; 0.98g (2.4mmo1) of 2 ', 3', 4 ', 6' -tetra-O-acetyl-. alpha. -D-bromoglucose was dissolved in 5mL of acetone solution and added dropwise to the first mixed solution to conduct a reaction, stirred at room temperature, checked by TLC, developing solvent: v (ethyl acetate): v (petroleum ether) ═ 1: 2. When the reaction was complete, the solvent was removed by rotary evaporation under reduced pressure, 200mL of dichloromethane were added to the bottle containing the residue, washed 2 times with water (2X 20mL), the aqueous phase was extracted 2 times with dichloromethane (2X 20mL), and the organic phases were combined. Drying the organic phase by anhydrous magnesium sulfate, filtering, decompressing, spin-drying and removing the solvent to obtain a crude product, and separating by silica gel column chromatography to obtain an intermediate (2-amino-5- (sulfo-1, 3, 4-thiadiazolyl) -2 ', 3', 4 ', 6' -tetra-O-acetyl-beta-D-glucose).
S2, dissolving 2.54mmol (0.355g) of raw material D with the structural formula shown as the following formula D in 4 mL of thionyl chloride in a 50mL three-neck flask, carrying out reflux reaction at 60 ℃ for 2 hours, fully spin-drying a reaction system, adding 1.0mmol of the intermediate (2-amino-5- (thio-1, 3, 4-thiadiazolyl) -2 ', 3', 4 ', 6' -tetra-O-acetyl-beta-D-glucose), 10mL of dichloromethane and triethylamine (TEA, 1.0mmol), stirring at room temperature, slowly dropwise adding a dichloromethane solution of 1.2mmol of acyl chloride, stirring for three hours, carrying out TLC tracking reaction, after the reaction is completed, quenching with water, separating out an organic phase, spin-drying, and recrystallizing a crude product with isopropanol to obtain the acetylglucose thiadiazole benzamide compound. Wherein the structural formula of the raw material D is as follows:
Figure BDA0002773301790000061
example 3
The material embodiment provides a synthesis method of an acetyl glucose thiadiazole benzamide compound, which has the following reaction route, wherein R is a substituent on a ring where the R is located, and is specifically 4-Br:
Figure BDA0002773301790000071
specifically, the synthesis method comprises the following steps:
s1, synthesis of intermediate (2-amino-5- (thio-1, 3, 4-thiadiazolyl) -2 ', 3', 4 ', 6' -tetra-O-acetyl- β -D-glucose): adding 400mg (0.01mol) of NaOH, 10mL of distilled water, 50mL of acetone solution and 1.33g (0.01mol) of 2-amino-5-mercapto-1, 3, 4-thiadiazole into a 50mL three-necked bottle, and stirring for 30min to obtain a first mixed solution; 0.98g (2.4mmo1) of 2 ', 3', 4 ', 6' -tetra-O-acetyl-. alpha. -D-bromoglucose was dissolved in 5mL of acetone solution and added dropwise to the first mixed solution to conduct a reaction, stirred at room temperature, checked by TLC, developing solvent: v (ethyl acetate): v (petroleum ether) ═ 1: 2. When the reaction was complete, the solvent was removed by rotary evaporation under reduced pressure, 200mL of dichloromethane were added to the bottle containing the residue, washed 2 times with water (2X 20mL), the aqueous phase was extracted 2 times with dichloromethane (2X 20mL), and the organic phases were combined. Drying the organic phase by anhydrous magnesium sulfate, filtering, decompressing, spin-drying and removing the solvent to obtain a crude product, and separating by silica gel column chromatography to obtain an intermediate (2-amino-5- (sulfo-1, 3, 4-thiadiazolyl) -2 ', 3', 4 ', 6' -tetra-O-acetyl-beta-D-glucose).
S2, dissolving 2.54mmol (0.508g) of raw material D with the structural formula shown as the following formula D in 4 mL of thionyl chloride in a 50mL three-neck flask, carrying out reflux reaction at 60 ℃ for 2 hours, fully spin-drying a reaction system, adding 1.0mmol of the intermediate (2-amino-5- (thio-1, 3, 4-thiadiazolyl) -2 ', 3', 4 ', 6' -tetra-O-acetyl-beta-D-glucose), 10mL of dichloromethane and triethylamine (TEA, 1.0mmol), stirring at room temperature, slowly dropwise adding a dichloromethane solution of 1.2mmol of acyl chloride, stirring for three hours, carrying out TLC tracking reaction, after the reaction is completed, quenching with water, separating out an organic phase, spin-drying, and recrystallizing a crude product with isopropanol to obtain the acetylglucose thiadiazole benzamide compound. Wherein the structural formula of the raw material D is as follows:
Figure BDA0002773301790000081
the synthesis of the acetyl bromo-glucose thiadiazole benzamide compounds containing different R substituents can be performed according to the synthesis methods provided in the above embodiments 1 to 3, wherein the spectral data of part of the acetyl glucose thiadiazole benzamide compounds are shown in table 1.
TABLE 1
Figure BDA0002773301790000082
Figure BDA0002773301790000091
Figure BDA0002773301790000101
Figure BDA0002773301790000111
Figure BDA0002773301790000121
Figure BDA0002773301790000131
In addition, the in vitro growth rate method in the prior art is adopted to determine the bacteriostatic activity of the acetylglucose thiadiazole benzamide compound. Specifically, a potato dextrose agar medium (PDA medium: 200g of potato, 20g of agar, 20g of glucose and 1000mL of distilled water) is heated to a molten state (50 ℃), 10mL of a liquid medicine (a liquid medicine containing 10 times of the final concentration of the acetylglucose thiadiazole benzamide compound) is poured into 90mL of the PDA medium, the mixture is fully shaken, and the mixture is uniformly poured into a culture dish with the diameter of 9cm, horizontally placed and cooled and solidified. And (3) punching a bacterium dish with the diameter of 4mm on the edge of the colony of the fresh pathogenic bacterium cultured for 4d by using a puncher, inversely placing the bacterium dish in the center of a PDA (personal digital assistant) plate containing a medicament, then placing the bacterium dish in a constant-temperature constant-humidity incubator at 27 ℃ for inverted culture, observing when a blank control colony grows to a position close to two thirds of the plate, measuring the diameter of the colony by using a cross method, and taking an average value. The blank was dosed with no agent, but contained the same concentration of solvent and 0.5% Tween 20, in triplicate for each treatment. The inhibition rate of the agent on the growth of hyphae is calculated by the following formula:
I(%)=(C-T)/(C-0.4)×100%;
wherein I is the inhibition, C is the blank control diameter (cm), and T is the treatment diameter (cm). 5 samples were assayed, dose-inhibition curves were plotted, and the EC was calculated50The value is obtained. Each sample was assayed in triplicate and the results expressed as mean ± standard deviation.
Through calculation, the EC of the acetylglucose thiadiazole benzamide compound synthesized in the example 1 on potato late blight pathogenic bacteria506.02. mu.g/mL.
In light of the foregoing description of the preferred embodiment of the present invention, many modifications and variations will be apparent to those skilled in the art without departing from the spirit and scope of the invention. The technical scope of the present invention is not limited to the content of the specification, and must be determined according to the scope of the claims.

Claims (8)

1. The acetyl glucose thiadiazole benzamide compound is characterized by having a structural general formula as shown in formula I:
Figure FDA0002773301780000011
wherein R is a substituent at any position on the ring.
2. The acetylglucose thiadiazole benzamide compound according to claim 1, wherein in the formula, R is H or 2-CH3、3-CH3、4-CH3、2-OCH3、3-OCH3、4-OCH3、2,3-(CH3)2、2,4-(CH3)2、2,5-(CH3)2、2,6-(CH3)2、2,3-(OCH3)2、2,4-(OCH3)2、2,5-(OCH3)2、2,6-(OCH3)2、2-F、3-F、4-F、2-Cl、3-Cl、4-Cl、2-Br、3-Br、4-BrPh、2-NO2、3-NO2、4-NO2、2-CF3、3-CF3、4-CF3At least one of (1).
3. A method for synthesizing the acetylglucosamine thiadiazole benzamide compound according to any one of claims 1-2, which comprises the following steps:
reacting the raw material A with the raw material B to obtain an intermediate C;
reacting the intermediate C with a raw material D to obtain the acetylglucose thiadiazole benzamide compound;
the structural formulas of the raw material A, the raw material B, the intermediate C and the raw material D are respectively shown as a formula A, a formula B, a formula C and a formula D:
Figure FDA0002773301780000012
Figure FDA0002773301780000021
4. the method for synthesizing the acetylglucose thiadiazole benzamide compound according to claim 3, wherein the step of reacting the raw material A with the raw material B to obtain the intermediate C specifically comprises:
mixing B, NaOH raw materials, distilled water and acetone to obtain a first mixed solution;
and preparing the raw material A into a solution, dropwise adding the solution into the first mixed solution for reaction, and then purifying and separating to obtain an intermediate C.
5. The method for synthesizing acetylglucose thiadiazole benzamide compound according to claim 4, wherein in the step (A), raw material A is prepared into an acetone solution of raw material A.
6. The method for synthesizing the acetylglucose thiadiazole benzamide compound according to claim 3, wherein the step of reacting the intermediate C with the raw material D to obtain the acetylglucose thiadiazole benzamide compound specifically comprises:
mixing the intermediate C, dichloromethane and triethylamine to obtain a second mixed solution;
and (3) mixing the raw material D with thionyl chloride, reacting completely, removing the thionyl chloride, preparing the residue into a solution, dropwise adding the solution into the second mixed solution, reacting, and purifying and separating to obtain the acetyl bromo glucose thiadiazole benzamide compound.
7. The method for synthesizing acetylglucose thiadiazole benzamide compound according to claim 6, wherein in the step (A), the residue is prepared as a dichloromethane solution of acid chloride.
8. Use of the acetylglucosamine thiadiazole benzamide compound as defined in any one of claims 1-2 for inhibiting potato late blight pathogenic bacteria.
CN202011256567.7A 2020-11-11 2020-11-11 Acetyl glucose thiadiazole benzamide compound and synthesis method and application thereof Active CN112341506B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202011256567.7A CN112341506B (en) 2020-11-11 2020-11-11 Acetyl glucose thiadiazole benzamide compound and synthesis method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202011256567.7A CN112341506B (en) 2020-11-11 2020-11-11 Acetyl glucose thiadiazole benzamide compound and synthesis method and application thereof

Publications (2)

Publication Number Publication Date
CN112341506A true CN112341506A (en) 2021-02-09
CN112341506B CN112341506B (en) 2022-05-06

Family

ID=74363519

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202011256567.7A Active CN112341506B (en) 2020-11-11 2020-11-11 Acetyl glucose thiadiazole benzamide compound and synthesis method and application thereof

Country Status (1)

Country Link
CN (1) CN112341506B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113896722A (en) * 2021-09-28 2022-01-07 内蒙古民族大学 Benzamide compound containing thiadiazole group and preparation method and application thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009037485A1 (en) * 2007-09-20 2009-03-26 Prolysis Ltd Antibacterial agents
CN104370982A (en) * 2014-05-19 2015-02-25 南开大学 Diphyllin derivatives, and preparation method and application thereof
CN105828610A (en) * 2013-10-22 2016-08-03 美国陶氏益农公司 Pesticidal compositions and related methods

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009037485A1 (en) * 2007-09-20 2009-03-26 Prolysis Ltd Antibacterial agents
CN105828610A (en) * 2013-10-22 2016-08-03 美国陶氏益农公司 Pesticidal compositions and related methods
CN104370982A (en) * 2014-05-19 2015-02-25 南开大学 Diphyllin derivatives, and preparation method and application thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
陈美航 等: ""具有杀菌活性的1,3,4-噻二唑类化合物的研究进展"", 《铜仁学院学报》 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113896722A (en) * 2021-09-28 2022-01-07 内蒙古民族大学 Benzamide compound containing thiadiazole group and preparation method and application thereof

Also Published As

Publication number Publication date
CN112341506B (en) 2022-05-06

Similar Documents

Publication Publication Date Title
US5514643A (en) 2-aminothiazolecarboxamide derivatives, processes for preparing the same and use thereof for controlling phytopathogenic organisms
CN108997253B (en) Mandelic acid derivatives containing 1,3, 4-oxadiazole thioether and application thereof
CA2552565A1 (en) Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics
CN112341506B (en) Acetyl glucose thiadiazole benzamide compound and synthesis method and application thereof
FR2471968A1 (en) BASIC ETHERS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
SU1050564A3 (en) Process for preparing derivatives of nitrothiphene
CA2539849A1 (en) Arylalkylcarbamate derivatives, preparation method thereof and use of same in therapeutics
CN105646392B (en) 1,3,4 oxadiazole class compounds, its preparation method and the application of the fat of oxime containing carboxylic acid
CN112175030B (en) Acetyl glucose triazole benzamide compound and synthesis method and application thereof
CN107663182B (en) Glutamine metabolism inhibitor compound
JPH03505092A (en) Tricyclic lipoxygenase inhibiting compounds and compositions thereof
US5026729A (en) Lipoxygenase inhibiting compounds
CN106986801A (en) A kind of new methoxy acrylic ester compounds and its preparation method and application
CN105906581B (en) A kind of chiral spiral shell 1,2,3- thiadiazoles derivatives and its synthetic method and application with antibacterial activity
CN113563281A (en) Benzophenone compound containing 1,3, 4-thiadiazole thioether structure and application thereof
CN112898223A (en) 1,3, 4-oxadiazole compound containing sulfonate/carboxylate structure and preparation method and application thereof
CN104326918A (en) Compound 3-fluoro-4-hydroxy-5-nitro-1-phenyl butanone and preparation method and agricultural biological activity thereof
CN116239551B (en) Furanylurea compound with molluscicidal activity and preparation and application thereof
CN113896722B (en) Benzamide compound containing thiadiazole group and preparation method and application thereof
CN116730947B (en) 2,4, 5-Trisubstituted thiazole compound and preparation method and application thereof
CN112979637B (en) Thiazole compound with antibacterial property and application thereof
CN117343024A (en) Chalcone derivative containing benzoxazole structure and preparation method and application thereof
FR2462416A1 (en) NOVEL DERIVATIVES OF NITROALCANOLS, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING SUCH SUBSTANCES FOR USE IN THE PROTECTION OF PLANTS
JP2779905B2 (en) Industrial antibacterial agent and industrial antibacterial composition containing the same
KR100201583B1 (en) Novel amino acid amide derivative and process for preparing the same

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant